10X Genomics announced enhancements to its Xenium platform, enabling simultaneous RNA and protein detection in the same cell, along with ready-to-use protein subpanels.
2 reports, 2 independent
Updated Aug 19
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
10X Genomics announced enhancements to its Xenium platform, enabling simultaneous RNA and protein detection in the same cell, along with ready-to-use protein subpanels.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
10X Genomics
American biotechnology company
Nothing else this week.
Coverage
Newest first; wire copies grouped- PR Newswire10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein
- StockStoryTXG Q2 Deep Dive: Robust Product Demand and Cautious Outlook Amid Funding Uncertainty Biotech company 10x Genomics (NASDAQ:TXG) reported Q2 CY2025 results topping the market’s revenue expectations ,